Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ALPK1 |
| Upstream (Parents) |
|---|
| (<<) SOCS6 → ALPK1 |
| (<<) CDKAL1 → ALPK1 |
| (<<) UBQLN4 → ALPK1 |
| (<<) ALMS1 → ALPK1 |
| (<<) NACAP1 → ALPK1 |
| (<<) DPY19L4 → ALPK1 |
| Downstream (Children) |
|---|
| ALPK1 → EFHC2 (>>) |
| ALPK1 → CRISP1 (>>) |
| ALPK1 → OLAH (>>) |
| ALPK1 → AGBL3 (>>) |
| ALPK1 → HTR3B (>>) |
| ALPK1 → CALY (>>) |
| ALPK1 → C1orf68 (>>) |
| ALPK1 → NCAN (>>) |
| ALPK1 → ADAMTS7 (>>) |
| ALPK1 → KRT84 (>>) |
| ALPK1 → HTR2A (>>) |
| ALPK1 → ADAM19 (>>) |
| ALPK1 → LOC654056///SIRPB1 (>>) |
| ALPK1 → PLXNB2 (>>) |
| ALPK1 → SRD5A3 (>>) |
| ALPK1 → SLC12A5 (>>) |
| ALPK1 → ACRV1 (>>) |
| ALPK1 → UBQLN4 (>>) |
| ALPK1 → FLJ13197 (>>) |
